Pseudomonic acid (mupirocin) produced by Pseudomonas fluorescens is a polyketide antibiotic which blocks isoleucyl-tRNA synthetase. Knowledge of the biosynthetic pathways leading to pseudomonic acid production may help in engineering related antibiotics with other useful properties. To help define these pathways, we have isolated 13 non-producing mutants using Tn5 and Tn1725 mutagenesis. Seven of the Tn5 insertions mapped within a 55 kb region. The remaining insertions, and one gene encoding resistance to pseudomonic acid, mapped at separate locations. DNA that overlapped the seven clustered Tn5 insertions was isolated on a series of clones, extending over a region in excess of 60 kb. Non-producing mutants generated via gene disruption suggest that the biosynthetic cluster extends throughout this region.
INTRODUCTION
Pseudomonic acid A (mupirocin) is an antibiotic produced by the Gram-negative, aerobic bacterium Psetldomonas fltlorescens. It inhibits isoleucyl-tRNA synthetase, by blocking the formation of the enzyme. Ile-AMP complex, thus preventing the incorporation of isoleucine into growing peptide chains (Hughes & Mellows, 1978 . Its primary use has been in the treatment of skin infections by members of the bacterial genus Stapblococczrs (e.g. Scully e t al., 1992; Rice e t al., 1992) , but it has also been used to treat cutaneous candidiasis (Rode e t al., 1991) and in the control of burn wound infections (Rode e t a/., 1988) .
Pseudomonic acid consists of an unsaturated pentaketide and saturated C, fatty acid, 9-hydroxynonanoic acid, esterified by a branched C, unit (Fuller e t al., 1971 ; Chain & Mellows, 1974 Alexander et al., 1978; Fig. 1) . The pentaketide and C, unit together comprise monic acid, a complex molecule containing epoxide, diol and tetrahydropyran functions. In addition to pseudomonic acid A, fermentations yield other minor forms of pseudomonic acid that comprise around 5 % of the total product. These include pseudomonic acid B, which possesses an additional hydroxyl group in the ring (Chain & Mellows, 1977) , pseudomonic acid C, in which a double carboncarbon bond replaces the epoxide group (Clayton e t al., 1980 (Clayton e t al., ,1982 , and pseudomonic acid D, which possesses an unsaturated fatty acid side chain (O'Hanlon et al., 1983) . The contribution that these forms of pseudomonic acid make to the overall antibiotic activity is unclear.
The biosynthetic pathway to pseudomonic acid has not been characterized completely. However, the CI2, C,and C, units have been identified as products of separate On: Sat, 22 Dec 2018 01:28:40 C. A. WHATLING a n d OTHERS pathways that are subsequently assembled together (Martin & Simpson, 1989 ). An early suggestion that the c, unit and 9-hydroxynonanoic acid are derived from hydroxymethylglutaryl-CoA (HMG-CoA ; Feline et al., 1977) has been disproved (Martin & Simpson, 1989) . Instead, the entire molecule is derived from acetate, with the exception of C-16 and C-17, which are derived from the methyl of methionine (Feline etal., 1977) . It is believed that the acetate units are incorporated into monic acid and 9-hydroxynonanoic acid via a classical polyketide mechanism.
Many genes encoding components of polyketide synthases have been cloned and characterized (see Hopwood & Sherman, 1990 , for a review), revealing strong conservations across a wide range of species. The genes may be organized generally in one of two ways. For multifunctional type I synthases, all the component activities are encoded by large ORFs (e.g. Cortes e t al., 1990; Donadio et al., 1991; MacNeil e t al., 1992) . Moreover, several multifunctional enzymes may be involved in specific cycles of the same biosynthetic pathway, such that several large ORFs can be clustered together extending across a region in excess of 60 kb (e.g. Donadio e t al., 1991 ; MacNeil e t al., 1992) . Such organizations appear to have evolved as a means to facilitate the complex programming required for some polyketide biosyntheses (Donadio & Katz, 1992) . For type I1 synthases, the individual proteins are encoded by separate genes (e.g. Sherman etal., 1989; Bibb etal., 1989; Bergh & Uhlen, 1992) , although there is evidence for genes encoding proteins with more than one activity (e.g. Sherman et al., 1991; Summers e t al., 1992) . At least in Streptomjces, the corresponding genes involved in the biosynthesis of different polyketides are organized very similarly (Hopwood & Sherman, 1990) .
Although members of the genus Psezldomonas produce a number of polyketide-derived compounds (e.g. Fuller e t al., 1971; Nishiyama e t al., 1976; Mitchell & Young, 1978; Bender et al., 1993; Cuppels e t al., 1986; Defago, 1993; Ullrich e t al., 1994) , few studies have been undertaken to characterize the biosynthetic genes. Recently, a characterization of a 43 kb region involved in the biosynthesis of the polyketide phytotoxin, coronatine, by Psezldomonas yringae was described (Young et al., 1992; Ullrich e t al. , 1994) . This paper describes the identification of mutations blocking pseudomonic acid production and the location of a cluster of biosynthetic genes.
METHODS
Bacterial strains and culture conditions. The pseudomonic acid producers P. flilorescens NCIB 10586 and its reisolate P. flzlorescens 332 were used as parental strains. Eschericbia coli HBlOl (Boyer & Roulland-Dussoix, 1969 ) was used as the donor in conjugal matings, E. coli C600 (B. Bachmann, Yale University) and E. coli JM83 (Yanisch-Perron e t al., 1985) were used for routine cloning experiments, and E. coli P2392 (Raleigh et al., 1989) was used for propagation of the IEMBL3 library. Bacillzls szlbtilis 1604 (Moir et al., 1979 was used as the sensitive strain in bioassays. P.J?ziorescens strains were grown at 30 "C and E. coli and B. szlbtilis strains were grown at 37 OC, routinely in L-broth or on L-agar (Kahn et al., 1979) . Where appropriate, chloramphenicol was used at 800 pg ml-' for P. fluorescens, kanamycin at 50 pg ml-' for both P. jlzlorescens and E. coli, and benzylpenicillin at 200 pg ml-' for E. coli.
Plasmids and phage. pUC18 (Yanisch-Perron e t al., 1985) and pAT153 (Twigg & Sherratt, 1980) were used as general cloning vectors in E. coli. pRK2013 ) was used to mobilize plasmids from E. coli into P.jzlorescens. pLG221 (Boulnois e t al., 1985) and pSUP301: : Tn1725 (Simon et al., 1983; Tn1725 was introduced by V. Shingler, University of Umei, Sweden) were used to generate T n 5 (Berg, 1977; Berg et al., 1975) and Tn1725 (Ubben & Schmitt, 1986 ) mutants in P. fluorescens. IEMBL3 (Frischauf e t al., 1983) was used to prepare a genomic library of P. jzlorescens.
Molecular biological techniques.
Plasmid DNA isolations and transformations of E. coli and P. fluorescens strains were performed according to standard procedures (Sambrook et al., 1989) . Restriction enzymes, DNA ligase, calf intestinal alkaline phosphatase (CIP) and DNA polymerases were purchased from Gibco BRL, New England Biolabs or Northumbria Biologicals and used according to the manufacturer's instructions.
Genomic library construction and screening. Two genomic libraries of P. jzlorescens NCIB 10586 were constructed, in the plasmid pAT153 (Twigg & Sherratt, 1980) and in AEMBL3 (Frischauf et al., 1983 ). The pAT153 library was made by subcloning total ClaI-digested DNA into ClaI-linearized CIPtreated pAT153. The library was maintained as a collection of 8000 separate transformants and as a total plasmid preparation. The IEMBL3 library was constructed by subcloning Sazl3AI-digested DNA (size-fractionated on a sucrose gradient to enrich for fragments in the range 14-25 kb) between BamHI digested, CIP-treated left and right arms of the phage vector. This was maintained at 4 O C as a suspension of approximately 6000 p.f.u. ml-' in SM (0.05 M Tris/HCl, pH 7.5, 0.1 M NaC1, 8 mM MgS0,.7H20, 0.004% gelatin) containing a drop of chloroform, and propagated on E. coli P2392 according to standard procedures (Sambrook e t al., 1989) . The two libraries were screened by colony or plaque hybridization according to standard procedures (Sambrook e t al., 1989) .
Transposon mutagenesis. Tn5 and Tn1725 mutants of P. jzlorescens were isolated using the suicide vectors pLG221 and pSUP301: : Tn1725 respectively. Both plasmids can be conjugally transferred into P. JEuorescens, but cannot replicate in this host. As a consequence, P. fEuorescens transconjugants that acquired either kanamycin resistance or chloramphenicol resistance arose as a result of transposition of Tn5 or T n 1725 into the chromosome.
Conjugal matings. Plasmids were mobilized into P. jzlorescens via the helper plasmid pRK2013, which encodes all the functions necessary for conjugal transfer of the broad-host-range plasmid RK2 but cannot self-propagate in P. fltlorescens because it is based on the ColEl replicon. E. coli donor cells containing pRK2013 and the plasmid to be mobilized were grown to late exponential phase and P. jzlorescens recipient cells were grown to either mid or late exponential phase, both in 5 ml L-broth supplemented with appropriate antibiotics. Then 0.5 ml of each culture was filtered on to a sterile 0.45 pm filter and incubated on a dry L-agar plate overnight at room temperature or at 30 OC. The mating mixture was resuspended in 1 ml sterile saline solution and 0.1 ml aliquots of appropriate dilutions were spread on plates containing the appropriate antibiotic to select for transfer of the plasmid and pseudomonic acid (at 750 pg ml-l) to kill the E. coli donors. For the isolation of Tn5 mutants and gene disruption Pseudomonic acid biosynthetic genes in P. flt/0rescens mutants, kanamycin was used at a concentration of 50 pg ml-', and for the isolation of Tn1725 mutants, chloramphenicol was used at a concentration of 800 pg ml-'. In general, transconjugants arose after 2-4 d incubation at 30 "C and were then subcultured on to fresh plates.
Analysis of P. fluorescens chromosomal DNA using pulsed field gel electrophoresis (PFGE). Preparation of P. fruorescens chromosomal DNA, subsequent endonuclease digestion and separation of restriction fragments using PFGE has been described previously (Whatling & Thomas, 1993) .
Southern hybridizations. These were performed in general as described by Sambrook et al. (1989) . DNA probes were labelled according to a random priming technique, using [a-32P]dCTP (10 pCi p1-l; 370 kBq pl-'), random hexanucleotides (Sigma; at 90 absorbance units ml-l) and Klenow DNA polymerase (Gibco BRL). Pre-hybridization and hybridization buffers contained 5 x SSC, 50% formamide, 5 x Denhardt's reagent (0.1 YO Ficoll, 0.1 YO polyvinylpyrrolidone, 0.1 % BSA), 50 mM sodium phosphate, pH 6.5, 0.1 YO SDS and 250 pg denatured salmon sperm DNA ml-', and were used at 42 "C. Washes were performed twice using 2 x SSC, 0.1 YO SDS and 0.1 x SSC, 0.1 YO SDS for 30 min at 45 "C.
Gene disruption strategy. pUCl8, which cannot replicate in P.
fltlorescens, was used to construct a vector for performing gene disruption analysis in P. juorescens, since only if it carries chromosomal DNA derived from P. fEtrorescens can it propagate following homologous recombination with the chromosome. Two features were incorporated into pUC18 to render it appropriate for performing gene disruption. First, the apb gene from Tn5 was introduced on a 1.4 kb Sall-Hind111 fragment to give pCAW5, allowing selection for recombinants using kanamycin (P. fluorescens NCIB 10586 was resistant to 200 pg penicillin ml-'). Second, the origin of transfer (oriT) from RK2, which allows mobilization of plasmids via the helper plasmid pRK2013 from E. coli to P. juorescens, was introduced on a 0.7 kb BamHI fragment, giving pCAW5.1. pCAW5.1 was linearized by partial digestion with BamHI, end-filled with Klenow, and re-ligated to yield pCAW5.2 ( Fig. 5 ) which contains a single BamHI site to the left of oriT. In general, between 10 and 100 transconjugants were obtained per ml of mating mixture, the frequency decreasing with the size of the Sau3AI insert.
Bioassay for pseudomonic acid. P. j.vorescens colonies were picked on to Mupirocin Production Agar plates (MPA; containing, per litre: 2-3 g yeast extract, 1.1 g glucose, 2-6 g Na,HPO,, 2.4 g KH,PO,, 5.0 g (NH,),SO,, 1.5 % Oxoid agar) and grown for 1-2 d at 30 "C. Plates were overlaid with nutrient agar containing 4 ml of a culture of B. subtilis 1604 grown to late exponential phase and 0-5 ml of 5 % (w/v) 2,3,5-triphenyltetrazolium chloride (TTC) per 100 ml. After incubation overnight at 37 O C antibiotic production was recorded as clear zones around the bacterial colonies, against a red background (resulting from the reduction of TTC). Positive and negative controls were included on each plate. Levels of antibiotic production were measured in terms of the diameter of the zone of inhibition : parental levels gave zones of inhibition 3-4 cm in diameter ; intermediate-level production was scored when the zones of inhibition were less than half this diameter. To measure antibiotic levels in culture supernatants from shake-flask fermentations, samples were subjected to an overnight hole-inplate bioassay at 32 "C using Difco Sensitivity Test agar seeded with Difco B. subtilis spore suspension (0.8 ml per 300 ml molten agar). Zones of antibiosis produced by known concentrations of antibiotic were determined to estimate the titres of pseudomonic acid present.
HPLC analysis of mup non-producers. Extracts of wild-type and mup non-producers were analysed on a Waters C18 column using a buffer made from stock solutions of 0.5 M acetic acid (pH 6), 75 % (v/v) methanol and deionized H,O + 1 YO methanol, which were mixed in the ratio of 7 : 80: 13. The column was run with a flow rate of 2.5 ml min-l, at 40 "C, and a sample size of 10 ml was injected. The retention time for pseudomonic acid A detected at a standard wavelength of 260 nm was approximately 2.7 min.
RESULTS

Identification of mup mutants defective in pseudomonic acid biosynthesis
Several thousand P. flt/orescens 332 T n 5 and P. jhorescens NCIB 10586 Tn 7 725 mutants were individually bioassayed for pseudomonic acid production, first with plate bioassays, and then by testing culture filtrates from scaledd o w n shake-flask fermentations. T e n T n 5 and three 
A cluster of Tn5 insertions in mutants blocked for pseudomonic acid production
Tn5 and the surrounding chromosomal DNA was subcloned into pATl53 from the genome of mzlp mutants either as EcoRI fragments or as ClaI fragments. T h e plasmid containing Tn5 from mutant 10, pBROCl30, contained a 9.4 kb EcoRI fragment with T n 5 located approximately 3 kb from o n e end. To obtain a clone lacking Tn5, labelled chromosomal DNA from pBROC130 was used to probe a library of ClaI fragments in pAT153. A plasmid containing a n 11.8 k b fragment was identified. This plasmid, pBROC131, contained 3-3 k b of DNA in common with pBROC130 such that together they contained chromosomal DNA extending over a 17-6 kb region (Fig. 2a) .
To determine whether other transposon insertions mapped within the region covered by pBROC130 and pBROC131, the ClaI fragment from pBROC131 was used to probe EcoRI-digested DNA from the Tn5 mutants and SmaI-digested DNA from the Tn1725 mutants. In the in these mutants mapped within EcaRI fragments at least partly overlapping the 11.8 kb ClaI fragment. By constructing an EcoRI map for this region, the approximate location of each Tn5insertion was ascertained (Fig. 2b) AfnI and 105 kb AseI fragments which contained both groups of mutations, DNA from mutants map-202, -30, -33 and -75 digested with each enzyme was probed with chromosomal DNA located between map-202 and mtlp-210. In both cases, the hybridizing band for mutants map-202, -30 and -33 was retarded compared to that for mutant 75 (Fig. 3a, b) , indicating that they contained Tn5 in these mutants and therefore that map-202, map-30 and map-33 mapped to the same AflI and A d fragments.
The AfnI-AseI, AfnI-JpeI and Ad-SpeI fragments in which map-30, -33, -202 and -210 mapped were identified by probing double digests with Tn5 (Table 1) . Alignment of the fragments produced by single and double digestion in a restriction map implied that the 85 kb and 250 kb JpeI fragments were adjacent (Fig. 2c) Fig. 4 . Chromosome walking strategy used t o isolate the DNA located between mup-33 and mup-210 in the P. fluorescens genome. In the first step, a 0.7 kb EcoRI-BgllI fragment from pBROC130 and a 0.7 kb Kpnl fragment from pEX33 (a derivative of PAT153 containing Tn5 rescued from mutant 33 on a 6.9 kb Clal fragment) were used to probe a AEMBL3 genomic library. Of several clones identified, ACAW210.1 extended the furthest from mup-210, and ACAW33.1 and ACAW33.2 extended furthest from mup-33. Sall restriction maps were constructed for each of these phages, and these are presented since they were used in gene disruption experiments (Fig. 6) . Neither ACAW33.1 nor ACAW33.2 shared any overlap with ACAW210.1. In the second step, the 1.8 kb Sall end fragment from ACAW33.1 and 3.4 kb Sall end fragment from ACAW210.1 were used to probe the AEMBL3 library. The two clones that extended furthest from these probes were ACAW33.11 and ACAW210.17, respectively. Restriction mapping/probing indicated that these phages possessed approximately 6 kb of DNA in common. Abbreviations: Sa, Sau3Al, 5, Sall. (b) Asel-digested DNA from a range of P. fluorescens NClB 10586 recombinants containing cointegrated pCAW5.2 and the Tn5 mutants mup-33 and -90 probed with the 3.0 kb Xhol fragment from pBROC131. For mutant 90, the probe hybridized to the parental Asel fragment. In the case of mutant 33, this same fragment was retarded due to the presence of Tn5. For the recombinants, the 105 kb fragment was separated into two fragments, only one of which hybridized to the probe (i.e. the right-hand fragment shown in a). The low intensity of the signal for P. fluorescens::210.1:4.1 resulted from a low yield of DNA from this strain. (c) Sites of integration of pCAW5.2 derivatives in the P. fluorescens chromosome. Each derivative of pCAW5.2 was classified according to the origin of the Sau3Al fragment used to direct recombination. For example, constructs that contained a Sau3Al fragment isolated from the 5 kb Sall fragment from ACAW33.2 were designated 33.2: 5. N, where N was determined by the number of constructs derived from the same Sall fragment. The numbers above the map correspond to the size of the Sall fragment in which each pCAW5.2 derivative integrated. In cases where it was not possible to resolve the order of insertions within a single Sall fragment, the corresponding constructs have been grouped together. There is a gap in the map corresponding to DNA uniquely present in ACAW210.17. Gene disruption analysis has not been performed using DNA isolated from this phage. Pseudomonic acid biosynthetic genes in P. juorescens mup-210 mapped approximately 5 kb and 15 kb from the AseI site, respectively. Consequently it was possible that mup-30 and mup-33 could map anywhere up to 75 kb from mup-210. To determine the actual distance, the location of mup-30 and mup-33 was mapped more accurately.
mup-33 and mup-210 map approximately 24 kb apart
To determine the distance separating mup-33 and mup-210 the intervening DNA was isolated on a series of overlapping clones from a genomic library of P. juorescens NCIB 10586 in AEMBL3. This was achieved by walking from both mutations to a common region (Fig. 4) . Two walking steps were required to bridge the gap, providing genomic clones that extended over a total of 44 kb. Restriction analysis of the DNA located between mup-33 and mup-210 indicated that the two mutations are approximately 24 kb apart (this represents a maximum estimate: ACAW33.11 and ACAW210.17 were shown to contain at least three fragments in common, of sizes 2.5, 1.4 and 0.7 kb, but the exact limits of the overlap are likely to occur within different fragments). The Tn5 insertions in this region of the chromosome therefore extend over a total of 55 kb (i.e. from mup-33 to mup-200). In addition to the 24 kb of DNA between mup-33 and mup-210, a further 13 kb was isolated that extended in the opposite direction from mup-33 (i.e. in ACAW33.2), and approximately 6 kb of DNA was isolated that extended beyond mup-200 (these latter clones have not been subject to detailed analysis). Consequently, over 60 kb DNA from this region is available in cloned form.
Genes involved in the biosynthesis of pseudomonic acid may be located throughout the 24 kb region between mup-33 and mup-210, and for at least 13 kb beyond mup-33 A gene-disruption strategy was used to determine whether the DNA located between mup-33 and mup-210 contained genes involved in pseudomonic acid biosynthesis. It was reasoned that if biosynthetic genes were present, disruption could block the production of pseudomonic acid A. This type of approach has been used successfully to map other antibiotic biosynthetic genes (Chater & Bruton, 1983 ; Malpartida & Hopwood, 1986 ; Weber et al., 1990) .
Gene disruption employed pCAW5.2 (Fig. 5) , and relied on the failure of this plasmid to replicate autonomously in P. juorescens (see Methods). So that DNA around and between mzrp-33 and mup-210 could be targeted, DNA fragments from ACAW33.2, ACAW33.1, ACAW33.11 and ACAW210.1 were subcloned into pCAW5.2. This was done by isolating individual SaLI fragments, digesting with Sau3AI and subcloning the resulting fragments into the single BamHI site of pCAW5.2. Derivatives were obtained for each SaLI fragment, containing Sau3AI fragments ranging from 0.1 to 1 kb in size.
Individual pCAW5 . 2 derivatives were conjugally transferred into P. juorescens NCIB 10586 and transconjugants that acquired the kanamycin-resistance phenotype of pCAW5.2 were identified for further analysis. To confirm that pCAW5.2 had integrated, chromosomal DNA was isolated from representative transconjugants and digested with AseI (Fig. 6 ). This also allowed the approximate location of each integrate to be determined. Recombinants that were shown to contain homologously integrated pCAW5.2 were subsequently bioassayed for pseudomonic acid A production (Fig. 6 ).
Recombinants separated into three phenotypic classes (Fig. 6) . The majority produced parental or undetectable levels of antibiotic whilst two recombinants, P.
juorescens : : 33 .2 : 5 . 4 and P. juorescens : : 21 0 . 1 : 44.1 (see legend to Fig. 6 for explanation of these names), produced intermediate levels. Recombinants that produced parental levels of antibiotic most probably resulted from integration within an intergenic region or in a region that extended across a boundary of a gene. Those recombinants producing reduced or undetectable levels of antibiotic were presumed to have arisen from integration into a gene involved in pseudomonic acid biosynthesis. Integrations that blocked antibiotic activity were identified up to 8 kb from mup-33 and 7 kb from mup-210. This suggested that pseudomonic acid biosynthetic genes extend between mup-33 and mup-210. Whether biosynthetic genes traverse the entire region should be elucidated following gene disruption across the 5 kb of DNA unique to ACAW210.17. Inactivation of antibiotic activity was also possible using DNA up to the end of ACAW33.2. Thus it is probable that biosynthetic genes extend beyond the limits of ACAW33.2.
A gene known to confer resistance to pseudomonic acid A is not clustered with biosynthetic genes in P. fluorescens NCIB 10586
Two plasmids capable of conferring resistance to pseudomonic acid on E. coli were identified in the genomic library in pAT153, following replication of the library on to medium containing pseudomonic acid at 500 pg ml-l. One plasmid, pBROC128, complemented the E. coli ileS temperature-sensitive mutant 331 c- (Isaksson et al., 1977) , indicating that it encoded a P. jnorescens isoleucyl-tRNA synthetase, known from previous studies to be inherently resistant to pseudomonic acid (Hughes & Mellows, 1980) . This observation has been confirmed following DNA sequencing of the 5-8 kb insert of pBROC128 (Isaki et al., 1990) . The second plasmid, pBROCl32, contained a 21-3 kb insert. Using a combination of Tn1723 muta-genesis and subcloning, the relevant DNA was located to a 1.6 kb BamHI fragment of pBROC132. The mechanism of resistance encoded by this locus, denoted mzlpR, is currently unresolved.
On the premise that resistance genes are generally clustered with biosynthetic genes in bacteria, it was anticipated that mzlpR could map close to one of the T n 5 insertions inactivating pseudomonic acid biosynthesis. To determine whether this were the case, AseI-and AflIdigested DNA from the Tn5 mutants was probed with the 1.6 kb BamHI fragment. A 100 kb AseI fragment and 50 kb AflI fragment hybridized in each case (data not shown). Neither of these fragments corresponded to a fragment in which a Tn5 insertion mapped.
Since it was possible that m~p R mapped alongside biosynthetic genes for which mutants are not available, gene disruption analysis was also performed around mtrpR. Satr3AI fragments obtained from DNA extending 3-5 kb in one direction and 8 kb in the other direction from mtrpR were subcloned into pCAW5.2, and individual derivatives were conjugally transferred to P. jtrorescens NCIB 10586. Amongst a total of eight recombinants, none had any defect in pseudomonic acid production, as assessed by bioassay (data not shown). It would therefore seem unlikely that mtrpR is clustered with pseudomonic acid A biosynthetic genes.
DISCUSSION
This work has described the identification and preliminary characterization of a 60 kb region of the P. juorescens NCIB 10586 chromosome that is involved in pseudomonic acid biosynthesis. Using both transposon mutagenesis and a gene-disruption approach, mutations mapping at sites throughout this region have been shown to impair antibiotic production by P. jzlorescens NCIB 10586. For the seven Tn5 mutants that map here, this has been proved to be associated with a failure to accumulate pseudomonic acid, following HPLC analysis of culture extracts. Although the same information is not available for the gene disruption mutants, their location with respect to the Tn5 insertions strongly suggests that they too block pseudomonic acid production.
In addition to the genes mapping within the 60 kb region, at least three more genetic loci contributing to pseudomonic acid production have been identified by T n 5 mutations mapping at disparate sites on the P. juorescens chromosome. Preliminary results have indicated that two Tn1725 mutations (mutants 22 and 43) may also map at different sites. The amount of DNA associated with pseudomonic acid production at each of these sites is not known. As with the other transposon mutants, HPLC analysis has demonstrated that these mutants do not accumulate pseudomonic acid. It is possible that some of the mutated genes play an indirect role in pseudomonic acid production, for example in the supply of precursors to the biosynthetic genes : acetate and methionine metabolism could be relevant in this respect. Alternatively, some of the mutations could disrupt control circuits possibly involved in the activation of more idiosyncratic aspects of P. jHorescens metabolism. In this respect, it was demonstrated that mutations in a gene encoding glucose dehydrogenase could prevent the activation of biosynthesis of an antifungal compound by P. flzlorescens HV37a (Gutterson et al., 1988) . The similarities between polyketide and fatty acid biosynthesis may also entail some enzymes being common to the two processes. However, such possibilities may be qualified by the fact that none of the mutants display obvious physiological defects (including growth rate, morphological appearance, growth requirements, or accumulation of abnormal compounds detectable by the HPLC analysis) aside from the failure to accumulate pseudomonic acid. Interestingly, a gene that encodes resistance to pseudomonic acid, mupR, has been mapped to a site distinct from any of the loci involved in pseudomonic acid production. The significance of this observation awaits demonstration of the role of mupR in P.jtrorescens NCIB 10586; attempts to identify the phenotype of a mutant carrying a defective copy of mtrpR have so far proved unsuccessful.
Further analysis of pseudomonic acid biosynthesis will require characterization of genes within the biosynthetic cluster. Identification of the biosynthetic defects in the non-producing mutants will be helpful in this respect. In an attempt to identify possible homologues of known polyketide synthase genes, chromosomal DNA of P. fEElorescens NCIB 10586 has been probed with DNA from the actinorhodin, granaticin and tetracenomycin clusters (Malpartida & Hopwood, 1986; Sherman et al., 1989; Bibb e t al., 1989 ; DNA kindly provided by M. J. Bibb) and also with oligonucleotides designed on the basis of conserved domains within p-ketoacyl synthases. A sequence hybridizing to an act1 probe has been identified, but awaits characterization. Random DNA sequence analysis throughout the 60 kb region is also being performed, with the aim of finding ORFs that could encode components of a polyketide synthase.
